Clinical trials and regulatory bodies, including the MHRA (Medicines and Healthcare Products Regulatory Agency) and the EMA (European Medicines Agency), have approved it for managing diabetes and weight loss[1]
Formulated with Active Glow-zom Technology with Glutathione (50,000ppm), Niacinamide, Adenosine, Patented Skin-like Collagen, and Bifida Fermentation Lysate
Cancer Res 62:307312 Wang YC, Wang F, Sun TM et al (2011) Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells
The information and data provided is for information purposes only
What is LL-37
Other reported effects include: Headaches and dizziness Nausea and gastrointestinal discomfort Allergic reactions to B12 formulations (rare) If you experience symptoms suggesting a severe allergic reaction (difficulty breathing, severe rash, swelling of face/throat), seek emergency medical attention immediately by calling 999 or attending A&E
